TradingView
RocketTickers
May 3, 2021 7:35 PM
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sul
Long
NASDAQ:AMPH
60
Amphastar Pharmaceuticals, Inc.
NASDAQ
Description
⋅
May 3, 2021 7:35 PM
AMPH: Amphastar Pharmaceuticals, Inc.
2021-05-03 06:00:00
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection
Beyond Technical Analysis
More